Company / Current Assets
Nuvation Bio Inc. Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$571.5M
FY2025
5-year range
$526.3M / $772.1M
FY2021-FY2025
Trend
+8.6%
vs FY2024
Sector context
#104 of 213
Health Care
What the data says
At $572M, Nuvation Bio Inc.'s current assets ranks #104 of 213 in the Health Care sector. Current Assets returned to growth in FY2025 after 3 years of decline, reaching $572M.
Based on SEC 10-K filings.
$572M in FY2025 with a 5-year CAGR of +21.0%.
Declined from $616M to $572M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -5.0%
- 5-Year CAGR
- +21.0%
- 10-Year CAGR
- -
Sector benchmark
#104 of 213 in Health CareTop 49% of 213This company $571.5M Sector average $2.5B
▼
-77.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +21.0%, indicating consistent growth.
- In FY2025, current assets increased 8.6% year-over-year.
- Ranks #104 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $571.5M | +8.6% |
| FY2024 | $526.3M | -14.6% |
| FY2023 | $616.4M | -7.6% |
| FY2022 | $667.3M | -13.6% |
| FY2021 | $772.1M | +249.9% |
| FY2020 | $220.7M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026